Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Portfolio > ETFs > Broad Market

Nasdaq Warns Healthaxis About Stock Price

By Staff Writer

X
Your article was successfully shared with the contacts you provided.

NU Online News Service, April 18, 10:25 a.m. – Healthaxis Inc., Dallas, a company that develops Web software for health insurers, brokers and plan administrators, says the Nasdaq Stock Market, New York, could delist it from the Nasdaq National Market if the price of its stock fails to rise above $1 per share for 10 consecutive days by July 11.

Nasdaq recently sent Healthaxis a notice warning it that its stock had closed below $1 per share for a period of 30 consecutive trading days.

Nasdaq normally requires that stocks included in its National Market sell for more than $1 per share.

If Healthaxis continues to have trouble getting the price of its stock up, it could appeal the decision to delist it, or it could apply to transfer its stock to the Nasdaq SmallCap Market, the company says.

“The company believes that if it were to apply to transfer its stock to the Nasdaq SmallCap Market, its application would be approved,” Healthaxis says.

Healthaxis emphasizes that the company complies with all Nasdaq National Market financial requirements except for the minimum stock price rule.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.